The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Update in Sjögren syndrome
Abstract
Sjögren syndrome (SS), the second most common autoimmune rheumatic disease, refers to keratoconjunctivitis sicca and xerostomia resulting from immune lymphocytes that infiltrate the lacrimal and salivary glands. However, differential diagnosis remains confusing due to the high prevalence of vague symptoms of dryness, fatigue, and myalgias in the general population. The problems of diagnosis are further compounded by the finding of "positive" antinuclear antibodies in a high percent of the general population. Unless minor salivary gland biopsies are read by experienced observers, nonspecific changes of sialadenitis are frequently confused with the focal lymphocytic infiltrates that are characteristic of SS. The distinction between fibromyalgia patients with low titer antinuclear antibodies and primary SS remains difficult. Even in patients fulfilling strict criteria for SS, the genomic search for critical genes has proven difficult due to the multigenic pattern of inheritance and strong role of currently undefined environmental factors. No single environmental factor has been detected in the majority of SS patients. SS-like syndrome has been detected in certain patients with HTLV-1 and hepatitis C infection, providing clues to pathogenesis. Even in SS patients with marked sicca symptoms, minor salivary gland biopsy shows that almost 50% of glandular cells are still detected on biopsy. These results imply the importance of immune factors such as cytokines and autoantibodies in decreasing neuro-secretory circuits and induction of glandular dysfunction. Of potential importance, an antibody against muscarinic M3 receptor that can decrease secretory function when injected into rodents is frequently found in the sera of SS patients. Newly developed topical and oral therapies can ease the oral and ocular dryness. Orally administered agonists of the muscarinic M3 receptor (pilocarpine and cevimeline) have recently been approved by the US Food and Drug Administration to increase salivary secretion. Topical ocular use of low-dose corticosteroids or cyclosporin may decrease conjunctival surface inflammation. In a Phase II double-blind study, orally administered interferon alpha (150 U) led to improved saliva flow and symptoms. In pregnant patients with evidence of fetal distress, oral dexamethasone is preferred because this agent crosses the placenta effectively. In animal models, antagonists of tumor necrosis factor and inhibitors of de novo pyrimidine synthesis appear promising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fujita, J., Dobashi, N., Ohtsuki, Y., Yamadori, I., Yoshinouchi, T., Kamei, T., Tokuda, M., Hojo, S., Okada, H., & Takahara, J. (1999) · Lung · doi:10.1007/pl00007649 · Cited by 45
Cited by
Review: The physiology of saliva and transfer of drugs into saliva
Aps, J. K. M., & Martens, L. C. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2004.10.026 · Cited by 560
Xerostomia and the Geriatric Patient
Ship, J. A., Pillemer, S. R., & Baum, B. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50123.x · Cited by 456
Dry Mouth and Its Effects on the Oral Health of Elderly People
Turner, M. D., & Ship, J. A. (2007) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2007.0358 · Cited by 397
An update of the etiology and management of xerostomia
Porter, S. R., Scully, C., & Hegarty, A. M. (2004) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2003.07.010 · Cited by 378
Xerostomia: Clinical Aspects and Treatment
Cassolato, S. F., & Turnbull, R. S. (2003) · Gerodontology · doi:10.1111/j.1741-2358.2003.00064.x · Cited by 349
Metadata
- Authors
- Fox, R. I., Stern, M., & Michelson, P.
- Venue
- Current Opinion in Rheumatology
- Published
- 2000-09
- Volume
- 12
- Issue
- 5
- Pages
- 391-398
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W303895199
- Cited by
- 248
- References
- 1
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update in Sjögren syndrome. https://app.cochat.ai/papers/10.1097/00002281-200009000-00007
- The paper
- Fox, R. I., Stern, M., & Michelson, P. (2000). Update in Sjögren syndrome. Current Opinion in Rheumatology. https://doi.org/10.1097/00002281-200009000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.